Achondroplasia is the most common of the skeletal dysplasias and the most common condition associated with disproportionate short stature. The incidence is 1 in 10,000 to 1 in 30,000 live births, with more than 250,000 people affected worldwide. The disorder is transmitted as an autosomal dominant trait with complete penetrance. However, in more than 75% of affected infants, achondroplasia results from a new mutation. The genetic defect in more than 95% of cases is an argininefor-glycine substitution in amino acid 380 in the gene, mapped to band 4p16.3, that codes for fibroblast growth receptor 3 (FGFR3). This substitution results in a gain of function of the FGFR3 gene and decreased endochondral ossification and chondrocyte inhibition in growth plate cartilage. Advanced paternal age, especially older than 35 years, has been associated in sporadic cases. Homozygous mutation is fatal. A rare mutation leads to a condition known as severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN). Hypochondroplasia is a milder form of achondroplasia.
Fetal diagnosis often is suspected when long-bone foreshortening is discovered during third-trimester ultrasonography. However, families may be counseled inaccurately because other explanations for the ultrasonographic findings exist. Molecular diagnosis is available for confirmation. At birth, the condition can be confirmed radiologically with a skeletal survey that shows a contracted skull base, square-shaped long bones, trident hands, proximal femur radiolucency, and rhizomelic (proximal segment) long-bone shortening. Additional clinical features that aid in the diagnosis of newborns include macrocephaly and frontal bossing. The diagnosis has been delayed in up to 20% of patients when the condition is not suspected at birth. Additional characteristics noted during the first postnatal year include hypotonia and delay in motor development, although normal development usually is achieved eventually.
Life expectancy can reach close to the average, but newer evidence adds to the concern that age-specific mortality is increased at all ages. Abnormal linear bone growth leads to many predictable complications, some of which can be modified through anticipatory guidance and close monitoring.
Neurologic complications are the most concerning. Infants have large heads and can develop craniocervical junction narrowing. Spinal cord compression at the cervical medullary junction can lead to sudden death in infancy and, more commonly, causes hypotonia, which leads to developmental motor delays. Mechanical swings and carrier slings must be avoided to minimize movement of the infant's head. Surgical suboccipital decompression is indicated for lower limb hyperreflexia, clonus, and central hypopnea on polysomnography. Head size measurements and, if indicated, head ultrasonography are recommended at birth and regularly during early childhood to monitor ventricular size due to the risk of hydrocephalus. Vertebral bodies have short pedicles and narrow interpedicular distance. The spinal canal size decreases in relation to the size of the spinal cord as patients age, which can lead to lumbar spinal stenosis. Indications for laminectomy include claudication and lower extremity hyperreflexia.
Among the orthopedic complications are thoracolumbar gibbus deformity (hump), which typically develops by 4 months of age. Bowing of the lower extremities is present early, and external rotation of the hips, typically seen at birth, resolves after the patient begins to bear weight. Persistent kyphosis worsens with age, exacerbating spinal stenosis.
Brainstem compression may lead to central apnea, and midface underdevelopment can lead to obstructive apnea. Tonsil and adenoid tissue can obstruct in brief breathing by restricting space, and patients may benefit from tonsilloadenoidectomy. Respiratory dysfunction can result in abnormal gas exchange and is associated with increased risk for cognitive deficits. Patients who have achondroplasia otherwise typically would have near-normal intelligence. Eustachian tubes are short, and recurrent otitis media is common. Some degree of conductive hearing loss is found in up to 40% of affected adults. Speech delay and problems with articulation can result.
Obesity is common and particularly troublesome for the patient who has achondroplasia because it worsens lumbar lordosis and contributes to a higher rate of cardiac morbidity. Early degenerative joint disease and upper airway obstruction are exacerbated by obesity.
Weight-for-height-and-age growth curves have been developed specifically for patients who have achondroplasia, and consultation with a dietitian is recommended.
Growth hormone has been used in clinical trials, but its long-term benefits are questionable, and such therapy currently is not recommended. Limblengthening surgical procedures are somewhat effective yet arduous and, therefore, controversial. Research into FGFR3 tyrosine kinase inhibitors is underway with animal models; success has been limited thus far.
Comment: Dr Stratbucker outlines the anticipatory guidance and surveillance that pediatricians must perform to identify and prevent morbidity early. Pediatricians also must be aware of the psychosocial issues that children who have achondroplasia may face, such as the potential for low self-esteem and mental health issues. Referral to family support groups such as the Little People of America Web site at www.lpaonline. org, or introduction of families to others who have children of short stature may be helpful. Implementing home and school adaptations can help a child of shorter stature to function independently, and occupational therapists can be of assistance.
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